1-[2-(2,3,4,5,6-Pentahydroxycyclohexyl)oxyindol-1-yl]ethanone
| Internal ID | 08099a50-fa88-4654-baaf-ef401302bf0c |
| Taxonomy | Organoheterocyclic compounds > Indoles and derivatives > Indoles |
| IUPAC Name | 1-[2-(2,3,4,5,6-pentahydroxycyclohexyl)oxyindol-1-yl]ethanone |
| SMILES (Canonical) | CC(=O)N1C2=CC=CC=C2C=C1OC3C(C(C(C(C3O)O)O)O)O |
| SMILES (Isomeric) | CC(=O)N1C2=CC=CC=C2C=C1OC3C(C(C(C(C3O)O)O)O)O |
| InChI | InChI=1S/C16H19NO7/c1-7(18)17-9-5-3-2-4-8(9)6-10(17)24-16-14(22)12(20)11(19)13(21)15(16)23/h2-6,11-16,19-23H,1H3 |
| InChI Key | LEWQPDWOFQXSIC-UHFFFAOYSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C16H19NO7 |
| Molecular Weight | 337.32 g/mol |
| Exact Mass | 337.11615195 g/mol |
| Topological Polar Surface Area (TPSA) | 132.00 Ų |
| XlogP | -1.10 |
| Atomic LogP (AlogP) | -1.13 |
| H-Bond Acceptor | 8 |
| H-Bond Donor | 5 |
| Rotatable Bonds | 2 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.9106 | 91.06% |
| Caco-2 | - | 0.8001 | 80.01% |
| Blood Brain Barrier | + | 0.6000 | 60.00% |
| Human oral bioavailability | + | 0.5143 | 51.43% |
| Subcellular localzation | Mitochondria | 0.4095 | 40.95% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.9539 | 95.39% |
| OATP1B3 inhibitior | + | 0.9467 | 94.67% |
| MATE1 inhibitior | - | 0.9200 | 92.00% |
| OCT2 inhibitior | - | 0.8697 | 86.97% |
| BSEP inhibitior | - | 0.8380 | 83.80% |
| P-glycoprotein inhibitior | - | 0.9082 | 90.82% |
| P-glycoprotein substrate | - | 0.9176 | 91.76% |
| CYP3A4 substrate | - | 0.5264 | 52.64% |
| CYP2C9 substrate | + | 0.6110 | 61.10% |
| CYP2D6 substrate | - | 0.8247 | 82.47% |
| CYP3A4 inhibition | - | 0.8253 | 82.53% |
| CYP2C9 inhibition | - | 0.9143 | 91.43% |
| CYP2C19 inhibition | - | 0.7854 | 78.54% |
| CYP2D6 inhibition | - | 0.8908 | 89.08% |
| CYP1A2 inhibition | + | 0.6556 | 65.56% |
| CYP2C8 inhibition | - | 0.7928 | 79.28% |
| CYP inhibitory promiscuity | + | 0.6047 | 60.47% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.9500 | 95.00% |
| Carcinogenicity (trinary) | Non-required | 0.4511 | 45.11% |
| Eye corrosion | - | 0.9900 | 99.00% |
| Eye irritation | - | 0.9144 | 91.44% |
| Skin irritation | - | 0.8083 | 80.83% |
| Skin corrosion | - | 0.9409 | 94.09% |
| Ames mutagenesis | - | 0.5100 | 51.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.6867 | 68.67% |
| Micronuclear | + | 0.8200 | 82.00% |
| Hepatotoxicity | - | 0.6071 | 60.71% |
| skin sensitisation | - | 0.8915 | 89.15% |
| Respiratory toxicity | + | 0.5778 | 57.78% |
| Reproductive toxicity | + | 0.7000 | 70.00% |
| Mitochondrial toxicity | + | 0.5951 | 59.51% |
| Nephrotoxicity | - | 0.6850 | 68.50% |
| Acute Oral Toxicity (c) | III | 0.5710 | 57.10% |
| Estrogen receptor binding | - | 0.5512 | 55.12% |
| Androgen receptor binding | - | 0.7274 | 72.74% |
| Thyroid receptor binding | - | 0.5867 | 58.67% |
| Glucocorticoid receptor binding | - | 0.5354 | 53.54% |
| Aromatase binding | - | 0.6589 | 65.89% |
| PPAR gamma | + | 0.6290 | 62.90% |
| Honey bee toxicity | - | 0.9426 | 94.26% |
| Biodegradation | - | 0.7000 | 70.00% |
| Crustacea aquatic toxicity | - | 0.5655 | 56.55% |
| Fish aquatic toxicity | + | 0.7948 | 79.48% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 96.08% | 96.09% |
| CHEMBL2581 | P07339 | Cathepsin D | 94.60% | 98.95% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 92.37% | 95.56% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 90.21% | 91.11% |
| CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 88.34% | 86.33% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 85.16% | 89.00% |
| PubChem | 162931695 |
| LOTUS | LTS0209659 |
| wikiData | Q105150842 |